Virginia Biotechnology Association

News

Virginia Launches Micro-Loan Program

The Virginia Small Business Financing Authority has established a program to help entrepreneurs in Virginia. The Small Business Micro-Loan Program is designed to assist Virginia’s existing small businesses across the Commonwealth. Short-term loans are provided to help established businesses ... read more ».

Tau Therapeutics Files IND to Begin Phase Ib Clinical Trial

Tau Therapeutics, LLC has announced a major milestone in the search for a better way of treating cancer. The pharmaceutical company has filed an investigational new drug (IND) application with the US Food and Drug Administration (FDA) for approval to commence a Phase Ib trial with mibefradil, a ... read more ».

Diffusion Begins TSC Trial for Primary Brain Cancer

Diffusion Pharmaceuticals LLC has opened for enrollment a clinical trial testing the company’s lead drug candidate trans sodium crocetinate (TSC) as a first-line treatment for newly diagnosed primary brain cancer, also known as glioblastoma or GBM. Currently there is no cure for GBM and patients ... read more ».

Bode Acquires Chromosomal Laboratories

Bode Technology (Bode), a leading provider of forensic DNA services located in Lorton, has acquired Chromosomal Laboratories, Inc., a provider of DNA testing for immigration and private paternity. By adding this expertise to its portfolio of service offerings, Bode will utilize its vast ... read more ».

LeClairRyan Founder Joins Health Diagnostic Laboratory

LeClairRyan and Health Diagnostic Laboratory, Inc. (HDL, Inc.), have jointly announce that Dennis Ryan, co-founder of LeClairRyan, has accepted a position as the Executive Vice President of Health Diagnostic Laboratory. Ryan, who provided counsel on the establishment of HDL, Inc. in 2008 and has ... read more ».

Xydynia Receives CIT GAP Fund Investment

The Center for Innovative Technology (CIT) this week announced a $50,000 investment in Charlottesville-based Xdynia LLC, a drug development company with a new class of compounds targeting the Cav 3.2 Ca++ channel, a common pathway in the development of neuropathic pain. Current pain therapies are ... read more ».

VABIO Applauds “Year of the Entrepreneur” Declaration

The Virginia Biotechnology Association (VABIO) today announced its enthusiastic support for Governor Bob McDonnell’s declaration that 2012 shall be the “Year of the Entrepreneur” in Virginia. “We applaud the Governor’s support for research-based, high-wage technology start-ups that are ... read more ».

TREAT Act Offers Renewed Hope for Patients

The Biotechnology Industry Organization (BIO) praised Sen. Kay Hagan (D-NC) for introducing the Transforming the Regulatory Environment to Accelerate ... read more ».

Video: Best Practices for Winning Federal and State Grants

Click here for a video of the February 2, 2012 VABIO program entitled, “Strategies for Winning Federal & State Commercialization Grants.” The panel of experts focused on how to maximize success in winning non-dilutive federal commercialization grants such as SBIR & STTR awards. ... read more ».

Companies Expand Export through VEDP Program

Afton Scientific of Albemarle County, and Mediatech of Prince William County were among the six companies from across the Commonwealth to graduate from Virginia Economic Development Partnership’s (VEDP) Virginia Leaders in Export Trade (VALET) program. The six companies collectively have ... read more ».